Nuvaxovid™, vacina contra a COVID-19, é a primeira opção à base de proteína para adolescentes com idade entre 12 e 17 anos na Europa GAITHERSBURG, Md., 6 de julho de 2022 /PRNewswire/ — A Novavax, Inc. (Nasdaq: NVAX), uma empresa de biotecnologia dedicada ao desenvolvimento e à…
Related Posts
Atlas Publishes 2021 Sustainability Report
LONDON, July 27, 2022 /PRNewswire/ – Atlas Corp. (“Atlas”) (NYSE: ATCO) is pleased to announce it has published its 2021…
EMC Filtration Market by Product Type and Region – Global Forecast to 2027
DUBLIN, Sept. 8, 2022 /PRNewswire/ — The “EMC Filtration Market by Product Type (EMC Filters (1-Phase EMC Filters, 3-Phase EMC…
The North America High-performance Ceramic Coatings Industry is Expected to Reach $2.1 Billion by 2027
DUBLIN, June 27, 2022 /PRNewswire/ — The “High-performance Ceramic Coatings: North American Markets and Technologies” report has been added to…